Adenocarcinoma Trials in New York, United States
Conditions / Adenocarcinoma / New York, United States
Research into Adenocarcinoma spans multiple therapeutic approaches and trial phases.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00917384 | Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma | COMPLETED | PHASE3 |
| NCT00911118 | Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05241873 | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations | TERMINATED | PHASE1 |
| NCT04862780 | (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC | TERMINATED | PHASE1 |
| NCT05153408 | (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC | TERMINATED | PHASE1 |
| NCT05935748 | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) | TERMINATED | PHASE2 |
| NCT00127478 | A Long Term Safety Study With Atrasentan | COMPLETED | PHASE2/PHASE3 |
| NCT02387216 | A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC | TERMINATED | PHASE2 |
| NCT03037385 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT00106353 | Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors | COMPLETED | PHASE1/PHASE2 |